Virtus ETF Advisers LLC Clovis Oncology, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.96 $36,185 - $170,013	-57,437 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.43 - $3.14 $4,860 - $10,672	-3,399 Reduced 5.59%	57,437 $116,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $65,950 - $116,267	24,426 Added 67.09%	60,836 $165,000
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $7,685 - $10,979	-1,893 Reduced 4.94%	36,410 $162,000
Q2 2021 Aug 10, 2021	BUY	$5.02 - $7.05 $192,281 - $270,036	38,303 New	38,303 $222,000
Q4 2020 Feb 12, 2021	SELL	$4.13 - $6.41 $357,075 - $554,202	-86,459 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $35,099 - $56,217	7,282 Added 9.2%	86,459 $504,000
Q2 2020 Aug 05, 2020	BUY	$5.69 - $9.69 $190,176 - $323,868	33,423 Added 73.05%	79,177 $534,000
Q1 2020 May 14, 2020	SELL	$3.77 - $11.0 $14,555 - $42,471	-3,861 Reduced 7.78%	45,754 $291,000
Q4 2019 Feb 13, 2020	SELL	$3.0 - $16.43 $11,670 - $63,912	-3,890 Reduced 7.27%	49,615 $517,000
Q3 2019 Nov 12, 2019	SELL	$3.93 - $15.35 $35,385 - $138,211	-9,004 Reduced 14.4%	53,505 $210,000
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $800,740 - $1.6 Million	62,509 New	62,509 $930,000
Q1 2019 May 14, 2019	SELL	$17.66 - $30.28 $545,270 - $934,925	-30,876 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$11.63 - $32.67 $160,203 - $450,029	13,775 Added 80.55%	30,876 $555,000
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $34,392 - $57,941	1,171 Added 7.35%	17,101 $502,000
Q2 2018 Aug 10, 2018	BUY	$42.06 - $62.4 $76,843 - $114,004	1,827 Added 12.95%	15,930 $724,000
Q1 2018 May 14, 2018	SELL	$50.12 - $67.72 $41,399 - $55,936	-826 Reduced 5.53%	14,103 $745,000
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $81,919 - $120,103	-1,420 Reduced 8.69%	14,929 $1.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,349	16,349 $1.53 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account